ICR strategic commercial partner raises $226.5m in financing 18 Sep 2023 Apollo Therapeutics, a strategic partner of The Institute of Cancer Research, has raised more than $226m from investors to fund its ongoing collaboration with the ICR and other academic partners. Find out more Show/Hide